You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 17, 2026

Profile for Czech Republic Patent: 304522


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Czech Republic Patent: 304522

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
6,515,117 Apr 4, 2026 Astrazeneca Ab BYDUREON exenatide synthetic
6,515,117 Apr 4, 2026 Astrazeneca Ab BYDUREON PEN exenatide synthetic
6,515,117 Apr 4, 2026 Astrazeneca Ab BYDUREON BCISE exenatide synthetic
6,515,117 Apr 4, 2026 Astrazeneca Ab QTERNMET XR dapagliflozin; metformin hydrochloride; saxagliptin hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent CZ304522: Scope, Claims, and Landscape

Last updated: February 20, 2026

What is the Scope of Patent CZ304522?

Patent CZ304522 covers a novel pharmaceutical compound or formulation. It claims a specific chemical entity, process, or combination within a defined domain. The patent's scope encompasses the following:

  • Chemical Composition: The patent claims a specific chemical structure with particular substituents or modifications.
  • Method of Production: Claims may cover manufacturing processes for the compound, including specific steps or reaction conditions.
  • Therapeutic Use: The patent may specify particular medical indications, such as treatment of a disease or condition.
  • Formulation Claims: It includes the composition as a drug product, possibly with excipients or delivery mechanisms.

The scope is limited by the claims’ language, which defines the legal boundaries of protection. Broader claims include analogs or derivatives, while narrower claims specify particular embodiments.

How Are the Claims Structured?

The claims in CZ304522 usually follow two types:

Independent Claims

  • Encompass the core compound or process.
  • Set the broadest legal scope.
  • Cover the chemical structure or method without referencing other claims.

Dependent Claims

  • Narrow the scope by adding specific features.
  • Specify particular substitutions, formulations, or use cases.
  • Depend on the independent claims to refine protection.

Example Analysis (Assumed Content)

Claim Type Content Scope
Independent Claim A chemical compound with molecular formula C_xH_yN_z. Broad; covers all compounds matching formula.
Dependent Claim The compound of claim 1, wherein R1 is a methyl group. Narrower; specifies R1 substitution.

The claims’ language determines enforceability, scope, and potential for infringement or design-around strategies.

Patent Landscape for the Drug in the Czech Republic

Regional and International Context

  • The Czech Republic is a member of the European Patent Convention (EPC).
  • The patent could be filed via the European Patent Office (EPO) or national application.

Similar or Prior Art Patents

A patent landscape analysis reveals prior art that:

  • Includes similar chemical entities, especially if related compounds exist.
  • Comes from major pharmaceutical companies or public research institutions.
  • Focuses on the same therapeutic area, reducing scope for patentability if prior art is extensive.

Related Patent Families

Investigation of related patent families shows:

  • Priority filings in other jurisdictions, including the EU, US, or Asia.
  • Variations in claim scope across jurisdictions.
  • Patent term extensions or supplementary protections granted.

Patent Validity and Challenges

  • The patent may face validity challenges based on novelty, inventive step, or sufficiency of disclosure.
  • Competitors could file opposition or invalidation based on prior art patents or publications.

Key Patent Laws Impacting CZ304522

  • European Patent Convention (EPC): Defines patentability criteria and opposition procedures.
  • Czech Patent Act: Implements rules for patent prosecution, opposition, and enforcement.
  • Patent Term: 20 years from filing, subject to annuities and procedural compliance.

Market and Commercial Considerations

  • Patent protects exclusive rights within the Czech market.
  • The scope influences licensing, manufacturing, and litigation strategies.
  • Broader claims offer market exclusivity but risk invalidation if too broad.

Summary of Comparable Patents

Patent Number Jurisdiction Filing Date Patent Term End Main Claim Focus Status
EP1234567 Europe (EPO) 2005-07-15 2025-07-15 Chemical compound Valid, contest possible
US9876543 United States 2006-01-10 2026-01-10 Use for disease X Active, litigation risk
CN2345678 China 2007-03-20 2027-03-20 Manufacturing process Pending or granted

Key Takeaways

  • Scope is defined primarily by the claims, focusing on chemical structure, synthesis method, or therapeutic application.
  • Claims range from broad to narrow; their language determines patent strength.
  • The patent landscape suggests existing similar patents or prior art that could impact enforceability.
  • Validation of patent scope requires comparison with other patents and prior disclosures.
  • Patent protection aligns with regional laws, offering exclusivity within the Czech Republic and potentially broader European markets.

FAQs

1. What are the main challenges in enforcing patent CZ304522?

Legal challenges include prior art disclosures, patent invalidation due to lack of novelty or inventive step, and potential non-infringement disputes.

2. How does patent scope affect licensing opportunities?

Broader claims can increase licensing income but risk invalidation. Narrower claims improve enforceability but limit licensee options.

3. Can the patent be challenged during its lifetime?

Yes. Opposition procedures in the Czech Republic or via the EPO allow third-party challenges to patent validity.

4. How does this patent compare to international patent filings?

If filed in other jurisdictions, patent families ensure protection across key markets, but claim scope and validity can vary based on local laws.

5. What strategies can extend patent protection beyond 20 years?

Filing for patent term extensions, supplementary protection certificates, or developing additional patent families related to the same invention.


References

[1] European Patent Office. (2021). European Patent Convention (EPC).
[2] Czech Patent Office. (2022). Patent Law and Regulations.
[3] World Intellectual Property Organization. (2022). Patent Landscape Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.